Related Experiment Videos

Anoxia-inducible rat VL30 elements and their relationship to ras-containing sarcoma viruses

B A Firulli1, G R Anderson, D L Stoler

  • 1Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, New York 14263-0001.

Journal of Virology
|November 1, 1993
PubMed

Insights

VL30 elements recombine with oncogenes in sarcoma viruses, aiding cancer development. This study details VL30 recombination boundaries and mechanisms in Harvey murine sarcoma virus and Kirsten murine sarcoma virus.

Area of Science:

  • Molecular Biology
  • Virology
  • Oncology

Background:

  • VL30 elements are retrotransposons implicated in cancer due to overexpression and recombination into sarcoma viruses.
  • Harvey murine sarcoma virus (HaSV) and Kirsten murine sarcoma virus contain ras oncogenes flanked by VL30 sequences.
  • Key questions exist regarding the recombination, boundaries, and function of VL30 elements in these viruses.

Purpose of the Study:

  • To elucidate the recombination mechanisms and precise boundaries of VL30 elements within HaSV and related sarcoma viruses.
  • To understand the role of VL30 sequences in the formation and potential oncogenic activity of HaSV.

Main Methods:

  • Isolation of VL30 clones from anoxic fibroblast cDNA library.
  • Polymerase chain reaction (PCR) cloning of VL30 elements from rat cell DNA.
  • Sequence comparison analysis between VL30 clones and HaSV sequences.

Main Results:

  • HaSV formation involved substitution of VL30 sequences by c-Ha-ras, potentially facilitated by an Alu-like repeat.
  • Precise recombination points for VL30 and c-Ha-ras in HaSV were identified.
  • Similar recombination events were observed in Kirsten murine sarcoma virus and Rasheed sarcoma virus.

Conclusions:

  • VL30 elements integrate into sarcoma viruses through specific recombination events.
  • Identified recombination sites and shared sequences provide insights into VL30's role in viral oncogenesis.
  • The findings clarify the structural basis of VL30 incorporation into oncogenic retroviruses.

Related Concept Videos